russ2000_2_0355|KNSA|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0355|KNSA|Long Name|Kiniksa Pharmaceuticals Ltd Total Current Assets (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Cash and Short Term Investments (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Inventories (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net PP&E (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Goodwill and Intangibles (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Current Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Long Term Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Deposits (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Book Value (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Retained Earnings (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Treasury Stock (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd EV to Revenues|Kiniksa Pharmaceuticals Ltd EV to Earnings|Kiniksa Pharmaceuticals Ltd EV to Free Cash Flow|Kiniksa Pharmaceuticals Ltd EV to Assets (Quarterly)|Kiniksa Pharmaceuticals Ltd PS Ratio|Kiniksa Pharmaceuticals Ltd PE Ratio|Kiniksa Pharmaceuticals Ltd Price to Book Value|Kiniksa Pharmaceuticals Ltd PEG Ratio|Kiniksa Pharmaceuticals Ltd Debt to Equity Ratio|Kiniksa Pharmaceuticals Ltd Dividend Yield|Kiniksa Pharmaceuticals Ltd Shareholder Yield (TTM)|Kiniksa Pharmaceuticals Ltd Percent of Shares Outstanding Short|Kiniksa Pharmaceuticals Ltd Total Receivables (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Payables (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Capital Stock (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Return on Invested Capital|Kiniksa Pharmaceuticals Ltd Quality Ratio Score|Kiniksa Pharmaceuticals Ltd Momentum Score|Kiniksa Pharmaceuticals Ltd Beta (1Y)|Kiniksa Pharmaceuticals Ltd Sustainable Growth Rate (TTM)|Kiniksa Pharmaceuticals Ltd Institutional Investor Ownership Percentage|Kiniksa Pharmaceuticals Ltd Average Diluted Shares Outstanding (Quarterly)|Kiniksa Pharmaceuticals Ltd Total Employees (Annual)|Kiniksa Pharmaceuticals Ltd EPS Diluted (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Dividend Per Share (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Revenue (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Gross Profit (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd SG&A Expense (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Pre-Tax Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net Interest Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Price (USD)|Kiniksa Pharmaceuticals Ltd Total Return Price (USD)|Kiniksa Pharmaceuticals Ltd Enterprise Value (USD)|Kiniksa Pharmaceuticals Ltd 30-Day Average Daily Volume|Kiniksa Pharmaceuticals Ltd 1 Year Price Returns (Daily)||
russ2000_2_0355|KNSA|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0355|KNSA|201703||||||||||||||||||||||||||||||||||32.467||-0.1522||||1.903|-4.974|-4.941|0.074|||||||
russ2000_2_0355|KNSA|201706||||||||||||||||||||||||||||||||||32.467||-0.3451||||2.12|-11.239|-11.203|0.153|||||||
russ2000_2_0355|KNSA|201709||||||||||||||||||||||||||||||||||32.467||-0.4937||||2.241|-16.08|-16.029|0.169|||||||
russ2000_2_0355|KNSA|201712|47.104|45.555||0.125||137.2|17.43|119.77||-89.708|-90.998|||||||||||||||1.218|0.001|||||||32.467|47|-1.0072||||2.78|-32.578|-32.701|0.133|||||||
russ2000_2_0355|KNSA|201803|222.453|221.108||0.126||19.298|19.268|0.03||205.477|-106.98|||||||||||||||2.796|0.011|||||||46.963||-0.3403||||3.71|-16.035|-15.982|0.305||||||19.47|19.47
russ2000_2_0355|KNSA|201806|363.869|359.19||0.35||23.33|23.144|0.186||341.799|-127.239||||-10.385||||4.0902|||0||0.0254||0.561|0.013|||||||18.3284||-1.11||||4.327|-20.461|-20.259|1.066|17.35|17.35|619.3399|||16.92|16.92
russ2000_2_0355|KNSA|201809|341.528|337.863||2.36||28.188|28.021|0.167||318.913|-151.645||||-13.3509||||3.6896|||0||0.9588||4.668|0.013|||||||48.1834||-0.51||||5.515|-24.537|-24.406|1.622|25.5|25.5|901.9048|199836.9667||23.92|23.92
russ2000_2_0355|KNSA|201812|313.75|307.304||6.356||42.698|42.554|0.144||279.267|-194.225||||-12.5473||||4.9779|||0||1.0771||10.918|0.013|||||||49.4896|111|-0.88||||8.013|-42.408|-42.58|1.727|28.09|28.09|1082.8589|113857.7||26.59|26.59
russ2000_2_0355|KNSA|201903|334.956|326.533||9.537||39.64|36.892|2.748||306.519|-260.046||||-7.809||||3.5136|||0||1.5442||6.89|0.015|||||||51.7584||-1.27||||8.394|-65.838|-65.821|1.809|18.06|18.06|673.9355|122333.5||17.89|17.89
russ2000_2_0355|KNSA|201906|296.458|287.447||8.862||32.94|30.178|2.762||275.197|-297.237||||-3.0437||||2.4165|||0||1.7714||9.338|0.015|||4|-1.5397|||54.4755||-0.68||||8.441|-37.565|-37.191|1.724|13.54|13.54|414.1646|111135.0667|-19.0675|13.35|13.35
russ2000_2_0355|KNSA|201909|268.34|258.745||8.627||29.894|27.56|2.334||251.911|-324.295||||-1.2463||||1.8536|||0||2||6.44|0.015|||2|-1.7569||33.9026|54.8313||-0.49||||8.432|-29.06|-27.058|1.386|8.51|8.51|208.2098|84198.1|-66.6275|8.17|8.17
russ2000_2_0355|KNSA|201912|241.627|233.38||8.325||29.111|27.83|1.281||225.423|-356.092||||-2.3162||||2.6954|||0||2.3489||5.693|0.015|||2|-0.8363||35.2009|54.8969|137|-0.58||||9.695|-31.451|-31.797|1.13|11.06|11.06|374.2299|306577.4667|-60.6266|11.19|11.19
russ2000_2_0355|KNSA|202003|213.055|204.206||7.433||20.274|19.342|0.932||205.834|-382.511||||-5.0957||||4.1801|||0||3.3944||4.274|0.015|||7|0.0145||42.2162|55.3227||-0.48||||8.486|-28.598|-26.419|0.789|15.48|15.48|656.1941|288174.7|-14.2857|15.08|15.08
russ2000_2_0355|KNSA|202006|264.493|252.398||6.533||21.025|20.552|0.473||250.416|-419.98||||-11.0045||||6.1546|||0||4.6083||2.373|0.016|||9|1.1949||48.604|57.9141||-0.65||||9.536|-31.594|-37.469|0.266|25.48|25.48|1288.8006|283311.8333|88.1832|25.53|25.53
russ2000_2_0355|KNSA|202009|||||||||||||||-6.7257||||4.1534|||0||4.8557||||||9|0.6035||46.4605|||||||||||15.32|15.32|787.6845|356360|80.0235|15.325|15.325